Metastatic Urothelial Carcinoma from Transplanted Kidney with Complete Response to an Immune Checkpoint Inhibitor

Figure 2

PET/CT scans showing improvement in metastatic disease with reduction in hepatic mass and decreased retroperitoneal, pelvic, and iliac lymphadenopathy after 4 cycles of pembrolizumab.